INTRODUCTION {#S5}
============

Obesity is increasing at an exponential rate worldwide. In the US it is estimated that 68% of the population are overweight, and 33.3% of men and 35.3% of women are obese.^[@R1],\ [@R2]^ Of pregnant women in the USA, 18-35% are estimated to be clinically obese.^[@R3]^ Further, children born to overweight/ obese women are at an increased risk of developing symptoms of the metabolic syndrome including obesity, insulin resistance, hyperglycemia, hyperlipidemia, hypertension, and cardiovascular disease.^[@R4],\ [@R5]^

In both rodents and sheep, there is a surge in leptin which occurs during the first 2-3 weeks of postnatal life^[@R6],[@R7]^ and this leptin surge is an important trophic factor in the establishment of hypothalamic circuits that control energy homeostasis and appetite.^[@R8],[@R9]^ Further, leptin has a powerful trophic action in the brain. *In vitro* exposure to leptin has been shown to increase the growth of axons from arcuate nucleus (ARC) neurons, which regulate feeding,^[@R10]^ and leptin administration to leptin-deficient ob/ob mice, only during the first few days of postnatal life, restored brain weight, and returned ARC projections to normal levels.^[@R10],[@R11]^

Diet-induced obesity during pregnancy modifies the postnatal leptin surge in offspring of several mammalian species including both altricial (rodents) and precocial (sheep) species leading to increased appetite, adiposity, as well as insulin and leptin resistance in adulthood.^[@R7],[@R12]^ Significant evidence indicates that insulin and leptin act on the brain as adiposity feedback signals.^[@R13]^ Additionally, neonatal leptin administration has been shown to normalize hyperglycemia and hyperinsulinemia and to increase insulin sensitivity.^[@R14]^

The "developmental origins of adult disease hypothesis", proposes that an adverse environment in early life can alter normal growth and development predisposing to obesity and other related diseases in adulthood.^[@R15]^ In agreement with this concept, increasing evidence indicates that some diseases do not have their beginnings in adulthood.^[@R16],[@R17]^ Evidence is now accumulating that demonstrates that the consequences of an environmental insult such as maternal overnutrition/obesity may not be limited to their immediate offspring (F1 generation), but may show multigenerational transfer to future generations.^[@R18],[@R19]^ In rodent models, cardiometabolic traits induced by direct exposure to early environmental conditions such as maternal overnutrition and /or obesity prior to conception, during pregnancy, and /or while nursing were observed in the subsequent unexposed generations. ^[@R20],[@R21]^ Similarly, studies in rodent models utilizing restricted diets (protein and/or energy) in F0 mothers during pregnancy and /or lactation have also reported programmed effects in both F1 and F2 generation offspring on birth weight, glucose tolerance, blood pressure and obesity.^[@R22]-[@R25]^ Human cohort studies especially the Dutch "winter hunger" studies have also provided additional evidence for multigenerational effects of maternal undernutrition on offspring adiposity and cardiometabolic disease. ^[@R26],[@R27]^ Studies in this area are inherently difficult to perform in human subjects. Therefore, the majority of current research has focused on animal models. While interspecies differences, particularly during the establishment of pregnancy and fetal development, do occur, the ability to control maternal diet and examine comprehensive outcomes at different developmental stages in a precocious and monotocous species such as sheep provides important insights and understanding of the impact of maternal obesity on fetal and offspring development.

The sheep is similar to humans in that the young are generally delivered in fewer numbers, and born after a greater degree of intra-uterine development. Further, the weight of pregnant ewes is similar to that of pregnant women, as is the ratio of fetal to maternal weight. Due to its long gestational length, and relative ease of fetal and maternal instrumentation, the sheep has emerged as a major animal model for studying the impact of malnutrition on the developing fetus and resulting offspring. While sheep are ruminants, and humans are monogastrics and require different diets, the fetus and newborn are dependent on glucose from the mother as the major energy source, and similar metabolic disturbances have been observed in the offspring of overnourished/obese ewes and women including hyperphagia, hyperglycemia, hyperinsulinemia, increased adiposity, and insulin resistance.^[@R12],[@R28],[@R29]^

The objective of this study was to evaluate the multi-generational impact of maternal overfeeding/obesity in F0 on glucose:insulin dynamics of their adult female offspring (F1) when fed only to requirements during pregnancy, and to evaluate the subsequent phenotype of their granddaughters (F2).

MATERIALS AND METHODS {#S6}
=====================

F1 generation {#S7}
-------------

All procedures were approved by the University of Wyoming Animal Care and Use Committee. Seventeen singleton Rambouillet/Columbia cross female F1offspring - born to either control (CON) ewes (n=7) fed a highly palatable pelleted diet (88.5% DM, 17.4% CP, 93.9% in-vitro dry matter digestibility) at 100% of National Research Council (NRC)^[@R30]^ recommendations or to obese overnourished (OB) ewes fed the same diet at 150% of NRC recommendations (n=10) from 60 days prior to conception to term, were utilized in this study. During lactation, all ewes (F0) were given free choice access to high quality alfalfa hay and were supplemented with cracked corn to meet NRC recommendations for a lactating ewe. OBF1 and CONF1 ewe lambs were housed together and fed at 100% NRC requirements from weaning until sexual maturity (2 to 3 years of age). F1 ewes were checked for estrus twice daily with a single intact Rambouillet/Columbia cross ram at 0700 and 1700 hr. All ewes conceived at first estrus, and CONF1 and OBF1 ewes continued to be fed at 100% of NRC recommendations from mating through weaning of their lambs. All F1 ewes were weighed and body condition scored at weekly intervals throughout pregnancy to evaluate changes in body composition. Body Condition Score is highly related to carcass lipids and can be used to estimate energy reserves available to the ewe.^[@R31]^ Jugular blood samples were collected from F1ewes at d0 (first day of mating), d45, d75, and d135 of gestation. Blood was collected into vacutainer tubes (BD Vacutainer, Franklin Lakes, NJ; serum tube 16 × 100, 10mL) without anticoagulant, allowed to sit for 1 hr at room temperature, and then refrigerated at 4°C overnight. Serum was collected after centrifugation (2500 × g for 15 min) the following morning and frozen at −80°C until analyzed for selected hormones and metabolites. Conception was verified via real time ultrasonography, at d45 and confirmed again at d60 (Ausonics Microimager 1000 sector scanning instrument, Ausonics Pty Ltd., Sydney, Australia).

F1 Intravenous glucose tolerance test {#S8}
-------------------------------------

Randomly selected pregnant F1 ewes (OBF1, n=6 and CONF1, n=6) were subjected to an intravenous glucose tolerance test (IVGTT) at d75 (midgestation) and again at d135 (late gestation). Ewes were fasted for 24 hrs prior to testing and then placed in individual pens with free access to water. Catheters (Abbocath, 14 ga, Abbott Laboratories, North Chicago, IL) were placed aseptically into the jugular vein 7h before blood sampling. A 124.5 cm extension set (Seneca Medical, Tiffin, OH) was attached to the catheter to allow for infusion and sampling without disturbing the animal. Baseline samples (\~ 6 mL) were collected 15 min before and immediately prior to administration of a glucose bolus infusion (0 min) (50% Dextrose, Vedco Inc., St. Joseph, MO), which was administered at a dose of 250 mg/kg of body weight. Blood samples were collected into chilled tubes (BD Vacutainer, Franklin Lakes, NJ; 143 U.S.P. units sodium heparin per 10 mL) at −15, 0, +2, +5, +10, +15, +20, +30, +45, +60, +90, and +120 min. Tubes were centrifuged at 2500 × g for 15 min and plasma frozen at −20°C until time of assay for glucose and insulin.

F2 morphometrics and blood collection {#S9}
-------------------------------------

F1 ewes were allowed to lamb unassisted. Twenty-five F2 lambs were born, CONF2, n=12 (5 males and 7 females) and OBF2, n=13 (7 males and 6 females). CONF1 ewes had 4 sets of twins and 4 singletons, while OBF1 ewes had 4 sets of twins and 5 singletons. Body weight and morphometric measurements (crown rump length, thoracic and abdominal circumferences, and biparietal distance) were recorded at birth. Blood samples were collected into chilled tubes (BD Vacutainer, Franklin Lakes, NJ; 143 U.S.P. units sodium heparin per 10 mL) from the lambs via jugular venipuncture at birth (pre-suckling), and then daily from postnatal d1 through d7 then again on d9 and d11. Lambs blocked by sex (male vs. female) and birth type (singletons vs. twins), were selected for postnatal hormone analysis.

Dual energy x-ray absorptiometry (DEXA) {#S10}
---------------------------------------

To accurately determine bone mineral density (BMD), bone mineral content (BMC), lean tissue mass, and fat tissue mass, Dual Energy X-ray Absorptiometry (DEXA, GE Lunar Prodigy™ 8743, Madison, WI) was utilized as previously described^[@R32]^ and validated for sheep.^[@R33],[@R34]^ Newborn F2 lambs were immobilized by wrapping them tightly in a large towel. This technique was less stressful on the lambs than tranquilizing them with ketamine, prevented excessive movement and had no effect on DEXA values (\< 1% difference). The whole body scan mode was used for all sheep, and scan times were 1-2 min depending on the size of the lamb. A single, blinded, and experienced investigator performed all DEXA scans and quantified body fat percentage, bone mineral density, and bone mineral content. DEXA was calibrated, and quality assurance tests were performed daily prior to measurement and according to the manufacturer's specifications and programmed acceptable limits.

Biochemical assays {#S11}
------------------

Plasma glucose was measured colorimetrically in triplicate (Liquid Glucose Hexokinase Reagent Set, Point Scientific, Inc., Canton MI) using 96-well plates as previously described.^[@R35]^ Mean intra-and inter-assay CV were 1.1% and 3.7%, respectively, with a sensitivity of 25 mg/dL. Plasma insulin was measured in duplicate by commercial RIA kit (Siemens Healthcare Diagnostics, Deerfield, IL). Intra- and inter-assay CV for insulin were 6.3% and 11.3%, with a sensitivity of 2.6 μIU/mL. Concentrations of cortisol were determined as described previously by Dong *et al*.^[@R36]^ using Coat-A-Count Cortisol RIA with a sensitivity of 0.5 ng/mL (Siemens Medical Solutions Diagnostics, Los Angeles, CA) with an intra- and inter-assay CV of 3.6% and 4.6% respectively. Plasma leptin concentrations were measured in a single assay using a commercial RIA (LINCO Multispecies Leptin RIA, Linco Research, St. Charles, MO) with an intra-assay CV of 5.2% and a sensitivity of 0.5 ng/mL.

Statistical analyses {#S12}
--------------------

Significance was set at P \< 0.05, with a tendency at P \< 0.10. To calculate fasted glucose and insulin levels from the IVGTT, baseline samples were averaged across the −15 min and 0 min samples. Comparison of maternal blood samples collected during the IVGTT at d0 (mating), d45, d75, and d135 of gestation and F2 postnatal blood samples (days 1 to 7, and on days 9 and 11) were analyzed as repeated measures using the Proc Mixed procedure of SAS (SAS Inst. Inc., Cary, NC). Area under the curve was measured using GraphPad Prism (GraphPad Software Inc., La Jolla, CA, USA). Gestation length, F2 lamb birth weights, percent fat, and bone mineral density at birth (determined by DEXA) was compared using the GLM procedure of SAS.

RESULTS {#S13}
=======

Gestation length of OBF1 (*P* \< 0.05) ewes was shorter than that of CONF1 ewes (151.2 ± 0.4 vs. 153.6 ± 0.5 days, respectively). Gestation length was similar for singleton and twin pregnancies. No treatment (OBF1 vs. CONF1) differences were observed in either body weight or BCS from conception through lambing (data not shown). While BCS remained relatively constant throughout pregnancy, body weights remained relatively constant through 8-10 weeks of gestation then progressively increased thereafter in association with the increase in gravid uterine weight in both groups.

During the IVGTT at day 75 (midgestation), OBF1 ewes demonstrated greater (*P* \< 0.05) fasting baseline glucose and insulin concentrations than CONF1 ewes (64.0 ± 4.0vs. 54.7 ± 1.3 mg/dL and 7.0 ± 2.2 vs. 3.4 ± 0.2 μIU/L, respectively). After glucose infusion, glucose concentrations remained greater in OBF1 ewes (area under the curve; *P* \< 0.01, [Fig.1A](#F1){ref-type="fig"}) than in CONF1 ewes during the post infusion period. Plasma insulin concentrations of OBF1 ewes during the IVGTT were also markedly increased (*P* \< 0.05) when compared to CONF1 ewes ([Fig.1B](#F1){ref-type="fig"}). During the IVGTT at day 135 (late gestation), fasted baseline glucose and insulin concentrations remained greater (*P* \< 0.05) in OBF1 vs. CONF1 ewes (62.3 ± 2.0 vs. 52.0 ± 2.0 mg/dL and 8.6 ± 1.1 vs. 4.2 ± 1.1 μIU/L, respectively). Further, after glucose infusion, plasma glucose and insulin concentrations were markedly increased in OBF1 ewes compared to CONF1 ewes (area under the curve; *P* \< 0.05, [Fig. 2A and 2B](#F2){ref-type="fig"}). Blood glucose concentrations obtained at day 0 (conception), day 45, day 75, and day 135 were elevated (*P* \< 0.01) in the OBF1 ewes in comparison to CONF1 ewes averaging 56.9 ± 3.6 and 48.8 ± 3.7 mg/dL, respectively over the whole period ([Fig. 3](#F3){ref-type="fig"}).

Postnatal DEXA scans showed OBF2 lambs had a greater percentage of body fat (*P* \< 0.01) than CONF2 lambs (9.7 ± 0.6% vs. 7.1 ± 0.6%, respectively) despite the similar birth weights in the two lamb groups ([Table 1](#T1){ref-type="table"}). Birth weight tended to be increased (*P* \< 0.10) in male vs. female newborn F2 lambs and in singletons compared to twins. Total fat (g) was greater (*P* \< 0.05) in OBF2 than CONF2 lambs, and also tended to be greater (*P* \< 0.10) in males versus females and in singles versus twins ([Table 1](#T1){ref-type="table"}). Also, bone mineral density and bone mineral content were lower (*P* \< 0.01) in female compared to male lambs ([Table 1](#T1){ref-type="table"}). Postnatal morphometric measurements, including crown rump length and right and left humerus length did not differ between treatment groups ([Table 2](#T2){ref-type="table"}). However, thoracic girth was decreased (*P* \< 0.05) in OBF2 vs.CONF2 lambs and also in twins vs. singletons. Abdominal girth also tended to be decreased (*P* \< 0.10) in OBF2 vs. CONF2 lambs.

Leptin concentrations were similar for CONF2 and OBF2 lambs from postnatal day 1 to 4. Thereafter, plasma leptin concentrations of CONF2 lambs increased (*P* \< 0.05) from postnatal day 4 to 7, remaining higher than values of OBF2 lambs from day 5 to day 9 before returning to pre-peak levels by day 11 ([Figure 4](#F4){ref-type="fig"}, Panel A). In contrast, leptin concentrations of OBF2 lambs remained constant from day 1 through day 11. At birth and on day 1 of postnatal life, plasma cortisol was elevated (*P* \< 0.01) in OBF2 lambs compared with CONF2 lambs ([Figure 4](#F4){ref-type="fig"}, Panel B). Plasma glucose concentrations were also higher (*P* \< 0.01) from birth through day 2 of postnatal life in OBF2 lambs ([Figure 4](#F4){ref-type="fig"}, Panel C) compared to CONF2 lambs. At birth through day 1, and again on day 5, plasma insulin levels of OBF2 lambs were greater (*P* \< 0.01) than those of CONF2 lambs. ([Figure 4](#F4){ref-type="fig"}, Panel D).

DISCUSSION {#S14}
==========

This is the first evidence using a large animal model demonstrating that maternal overnutrition/obesity can program granddaughters for increased adiposity at birth, and later in life. In the absence of excess nutrition or obesity, OBF1 ewes exhibited a greater insulin resistance, as evidenced by markedly increased insulin to glucose ratio in systemic blood, when compared to CONF1 ewes. We have previously reported, a positive correlation between insulin and glucose levels in the blood of OBF1 ewes demonstrating that more insulin is required per unit of glucose for transport into body tissues.^[@R28]^ This is consistent with research by Ahren and Pacini^[@R37]^ who reported that to compensate for insulin resistance, insulin output is enhanced, resulting in hyperinsulinemia in response to decreased insulin sensitivity in peripheral tissues. During normal human pregnancy, maternal pancreatic β-cells demonstrate remarkable plasticity. Significant adaptations are made in islet size and secretion capacity to meet the metabolic demand of pregnancy thus progressively increasing insulin secretion to compensate for insulin resistance, maintaining normal blood glucose concentrations.^[@R38],[@R39]^ However, offspring of obese mothers may be incapable of increasing insulin secretion to maintain proper glucose metabolism due to pre-programmed β-cell dysfunction, leading to hyperglycemia. Inadequate β-cell function in OBF1 ewes is demonstrated by the higher glucose at day 0 (mating), day 45, day 75, and day 135 in pregnant OBF1 ewes compared to pregnant CONF1 ewes.

Since glucose uptake by maternal tissues appears to be impaired, excess maternal glucose may be redirected into the fetal compartment. Glucose transport across the placenta is driven by the maternal:fetal glucose ratio and thus maternal hyperglycemia can lead to fetal hyperglycemia, hyperinsulinemia, enhanced glycogen synthesis, and lipogenesis.^[@R40]^ Glucose is the principal substrate supplying the uterus, placenta, and fetus^[@R41]^ and is an essential component in fetal growth, with concentrations increasing as gestation progresses.^[@R40]^ These data demonstrate that throughout pregnancy, F1 females born to OB mothers exhibit marked increases in insulin resistance when compared to F1 females born to CON mothers independent of a difference in maternal diet, potentially subjecting their fetuses to the same blood glucose elevations as their mothers during fetal life. Although birth weight in the F2 generation did not differ between treatment groups, newborn OBF2 lambs born to OBF1 ewes demonstrated markedly greater adiposity, as well as hyperglycemia and hyperinsulinemia when compared to CONF2 lambs. Similar to OBF1 and OBF2 lambs during the postnatal period, rodent offspring from obese mothers fed a high-fat diet showed similar birth weights to offspring born to control-fed mothers accompanied by increased adiposity.^[@R42]^ According to Caluwaerts *et al*.^[@R42]^ exposure of the rat fetus to maternal glucose intolerance or a diabetic intrauterine environment imposed by a maternal obesogenic diet may alter fetal metabolic pathways, facilitating fat accumulation and glucose intolerance in postnatal life. One reason for glucose intolerance in offspring developing in an obese intrauterine environment may be an increase in adipocyte size.^[@R42]^ Accumulation of additional lipid can cause mature, lipid-containing adipocytes to enlarge during the differentiation process.^[@R43]^ Once the capacity of lipid storage within the adipocyte is reached, excess energy substrates are redistributed to other organs, such as the liver, muscle, and pancreas, accompanied by insulin resistance^[@R44]^ resulting in ectopic fat deposition. Abnormal deposition of lipid is characteristic of type II diabetes, including glucose overproduction by the liver, insulin resistance at the muscle, and decreased insulin secretion by the pancreas.^[@R44]^

Across treatment groups, singleton F2 lambs tended to be heavier than twins and male F2 lambs tended to be heavier than F2 female lambs at birth. Additionally, DEXA scans revealed that male F2 lambs exhibited markedly greater BMD and BMC than F2 females regardless of birth type. Some studies claim individuals with a higher body weight have higher BMD than those with lower body weight at the same age,^[@R45]^ while others have failed to find gender-related differences in bone mass using DEXA scans.^[@R46]^ In this study, higher BMD and BMC in male lambs may be attributed to greater longitudinal and periosteal bone growth than female lambs.^[@R47]^ Fat percentages were similar across sexes and birth types. This may indicate that both males and females and singletons and twins were responding in a similar manner to the maternal intrauterine environment. According to Harrington *et al.*^[@R48]^ alterations in adipose tissue deposition between growth-restricted and appropriate-for-gestational age (AGA) infants arises because of differences in subcutaneous fat rather than intra-abdominal fat, since no differences in intra-abdominal fat were prevalent using magnetic resonance imaging scans. These authors suggest that subcutaneous and intra-abdominal fat depots may be under different regulatory control during intrauterine development. The increase in body weight but similar body fat percentages in male and female F2 newborn lambs may be attributable to visceral fat deposition as opposed to subcutaneous. It is important to note that sheep and humans deposit fat differently. Human infants are more likely to first deposit fat subcutaneously rather than intra-abdominally, have more subcutaneous fat at birth, and have a greater percentage of their body weight accounted for by fat mass than lambs (15% vs. 3% fat, respectively).^[@R49],[@R50]^ Further, it was reported by Stini^[@R51]^ that malnutrition in human infants reduces body fat from subcutaneous fat depots. Cnop *et al*.^[@R3]^ investigated the possible relationship between body fat distribution and insulin sensitivity and its relation to leptin levels in three different groups of individuals classified as lean insulin-sensitive (LIS), lean-insulin resistant (LIR), and obese insulin-resistant (OIR). These authors proposed that intra-abdominal fat was the most important predictor of insulin sensitivity, but fasting leptin levels (which were the highest in the OIR group) were more strongly associated with subcutaneous fat than intra-abdominal fat. Researchers have linked the increased deposition of intra-abdominal fat to insulin resistance^[@R52],[@R53]^ and other disorders comprising the metabolic syndrome,^[@R54],[@R55]^ suggesting that individuals with greater amounts of fat in this region experience disorders of the metabolic syndrome more often than those who distribute fat to peripheral locations.^[@R56],[@R57]^ Therefore, alternative fat deposition from intrauterine programming effects may predispose offspring to future glucose intolerance and hyperleptinemia in later life. Although associations have been made among fat mass, BMD, and BMC, further research is necessary to determine the role intrauterine programming plays in fat deposition and bone formation.

The neonatal leptin peak was eliminated in both OBF1^[@R7]^ and OBF2 lambs (present study) compared to CONF1 and CONF2 lambs, indicating a multi-generational effect. Bouret *et al*.^[@R58]^ has recently reported that leptin is essential for normal development of axonal projections from the arcuate nucleus to surrounding hypothalamic nuclei, thus programming the hypothalamic circuitry responsible for regulating appetite during postnatal life. Impairment in leptin receptor signaling may adversely affect axonal projections from the arcuate nucleus to their targets, affecting energy balance.^[@R58]^ In postnatal lambs, Muhlhausler *et al*.^[@R29]^ reported that mRNA expression of the leptin receptor in the arcuate nucleus of the hypothalamus was inversely related to fat mass. Elimination of this leptin peak may predispose rodent offspring of obese overnourished mothers to increased adiposity and decreased sensitivity to leptin in adulthood.^[@R10]^ Likewise, adult F1 females born to obese F0 ewes and subjected to *ad libitum* feeding exhibited markedly increased appetites, as well as glucose and insulin dysregulation, increased adiposity, and were hyperleptinemic when compared to F1females born to control-fed F0 ewes.^[@R12]^

OBF1 lambs^[@R7]^ and subsequently their offspring, OBF2 lambs (present study), exhibited elevated plasma cortisol levels on the day of birth and the beginning of postnatal life compared with CONF1 and CONF2 lambs. Cortisol has an important role in prenatal regulation of cell proliferation and differentiation to mature fetal tissues in preparation for extra-uterine life.^[@R59]^ Cortisol may cause premature differentiation of adipocytes, possibly altering the timing of the neonatal leptin peak and/or the quantity of leptin secreted. This idea is supported by Long *et al*.^[@R60]^ who reported that F2 offspring of ewes administered exogenous glucocorticoids during late gestation exhibited a similar elimination of the neonatal leptin peak as seen in offspring of overnourished/obese ewes and that this was associated with increased plasma cortisol from birth until day 2 of life. Further research is necessary to elucidate the mechanisms involving glucocorticoids, adipocyte differentiation, and leptin secretion.

Finally, these data do not conclusively demonstrate transgenerational epigenetic mechanisms, as the exposure of our Founder Generation (F0) to an obesogenic diet also resulted in the direct *in utero* exposure of the F1 generation, as well as F2 generation through germ-line exposure.^[@R19]^ They do, however, demonstrate a multigenerational effect resulting from a generationally recurring mechanism (e.g. gestational diabetes in MOF1) even in the absence of excess nutrition and obesity. Pregnancy may have constituted a "second hit", as these F1 mothers failed to exhibit an altered phenotype in the nonpregnant state. As discussed, both OBF1 and OBF2 lambs exhibit increased plasma levels of glucose, insulin, and cortisol at birth, increased visceral adiposity and the elimination of a postnatal leptin peak, known to program appetitic centers for later life in comparison to CONF1 and CONF2 lambs. A combination of maternal hyperglycemia, dyslipidemia, altered insulin-signaling, and obesity may result in altered intrauterine programming of the fetus leading to the potential to develop the metabolic syndrome in later life. As we have seen in our sheep model, exposure of adult offspring from OB ewes to a bout of ad libitum feeding induces hyperphagia, leading to increased adiposity, and intensifies preprogrammed insulin resistance and hyperglycemia when compared to CONF1offspring. These data suggest that to avoid the adverse health risks of the metabolic syndrome, eating only to requirements may not only benefit the mother and her own health, but the health of her daughters and granddaughters.
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![Glucose (A) and insulin (B) concentrations prior to and after glucose bolus infusion during an intravenous glucose tolerance test at day 75 of gestation in F1 ewes from obese (OBF1: ●) and control (CONF1: ○) dams fed at 100% NRC recommendations throughout gestation. Area under the curve (AUC) is located in the top right corner of each panel. \*Means ± SEM differ (*P* \< 0.05).](nihms-630110-f0001){#F1}

![Glucose (A) and insulin (B) concentrations prior to and after glucose bolus infusion during an intravenous glucose tolerance test at day 135 of gestation in F1 ewes from obese (OBF1: ●) and control (CONF1: ○) dams fed at 100% NRC recommendations throughout gestation. Area under the curve (AUC) is located in the top right corner of each panel. \*Means ± SEM differ (*P* \< 0.05).](nihms-630110-f0002){#F2}

![Glucose concentrations of F1 ewes from obese (OBF1: ●) and control (CONF1: ○) dams fed 100% NRC recommendations at day 0, 45, 75, and 135 of gestation. \*Means ± SEM differ (*P* \< 0.01).](nihms-630110-f0003){#F3}

![Plasma leptin, cortisol, glucose, and insulin in the early postnatal period (days 1 through 7 and again at days 9 and 11) in F2 lambs from obese (●) and control (○) grandmothers. \*Means ± SEM differ (*P* \< 0.01).](nihms-630110-f0004){#F4}

###### 

Birth weight and % fat determined by DEXA scans in F2 newborn lambs.

                         Treatment                                       Sex                                             Birth Type                                                                                                                                      
  ---------------------- ----------------------------------------------- ----------------------------------------------- ----------------------------------------------- ----------------------------------------------- ----------------------------------------------- -----------------------------------------------
  **Birthweight (kg)**   5.2 ± 0.2                                       5.0 ± 0.2                                       4.8 ± 0.2^[c](#TFN3){ref-type="table-fn"}^      5.4 ± 0.2^[d](#TFN4){ref-type="table-fn"}^      5.7 ± 0.3^[c](#TFN3){ref-type="table-fn"}^      5.1 ± 0.2^[d](#TFN4){ref-type="table-fn"}^
  **Body Fat (%)**       7.1 ± 0.6^[a](#TFN1){ref-type="table-fn"}^      9.7 ± 0.6^[b](#TFN2){ref-type="table-fn"}^      8.1 ± 0.6                                       8.7 ± 0.6                                       8.7 ± 0.9                                       7.7 ± 0.5
  **BMD (g)**            0.35 ± 0.01                                     0.33 ± 0.01                                     0.32 ± 0.01^[a](#TFN1){ref-type="table-fn"}^    0.38 ± 0.01^[b](#TFN2){ref-type="table-fn"}^    0.36 ± 0.02                                     0.35 ± 0.01
  **BMC (g/cm^2^)**      121.6 ± 7.7                                     120.5 ± 7.2                                     106.5 ± 7.0^[a](#TFN1){ref-type="table-fn"}^    135.6 ± 8.0^[b](#TFN2){ref-type="table-fn"}^    130.9 ± 11.2                                    122.7 ± 6.6
  **Fat (g)**            379.5 ± 26.5^[a](#TFN1){ref-type="table-fn"}^   493.0 ± 24.6^[b](#TFN2){ref-type="table-fn"}^   391.2 ± 24.1^[c](#TFN3){ref-type="table-fn"}^   481.2 ± 27.4^[d](#TFN4){ref-type="table-fn"}^   506.6 ± 38.3^[c](#TFN3){ref-type="table-fn"}^   407.7 ± 22.8^[d](#TFN4){ref-type="table-fn"}^

Means ± SEM differ (*P* \< 0.05)

Means ± SEM differ (*P* \< 0.05)

Means ± SEM differ (*P* \< 0.10). Newborn F2 lambs born to offspring from obese ewes fed 150% NRC recommendations (OBF2) and control ewes fed 100% NRC recommendations (CONF2).

Means ± SEM differ (*P* \< 0.10). Newborn F2 lambs born to offspring from obese ewes fed 150% NRC recommendations (OBF2) and control ewes fed 100% NRC recommendations (CONF2).

BMD= Bone Mineral Density; BMC=Bone Mineral Content.

###### 

Morphometrics at birth in F2 newborn lambs.

                 Treatment                                     Sex                                           Birth Type                                                              
  -------------- --------------------------------------------- --------------------------------------------- ------------ ------------ --------------------------------------------- ---------------------------------------------
  **CRL (cm)**   52.2 ± 1.1                                    50.1 ± 1.0                                    50.1 ± 1.0   52.2 ± 1.2   52.0 ± 1.6                                    51.4 ± 1.0
  **BPD (cm)**   15.6 ± 0.2                                    16.1 ± 0.2                                    15.8 ± 0.2   15.9 ± 0.2   16.4 ± 0.3                                    15.5 ± 0.2
  **RH (cm)**    14.9 ± 0.4                                    14.9 ± 0.4                                    14.5 ± 0.3   15.4 ± 0.4   15.0 ± 0.6                                    14.7 ± 0.3
  **LH (cm)**    15.0 ± 0.4                                    15.0 ± 0.4                                    14.6 ± 0.4   15.4 ± 0.4   15.2 ± 0.6                                    14.8 ± 0.4
  **TG (cm)**    41.4 ± 0.8^[a](#TFN5){ref-type="table-fn"}^   38.5 ± 0.7^[b](#TFN6){ref-type="table-fn"}^   38.9 ± 0.7   41.1 ± 0.8   42.9 ± 1.1^[a](#TFN5){ref-type="table-fn"}^   39.9 ± 0.6^[b](#TFN6){ref-type="table-fn"}^
  **AG (cm)**    42.2 ± 0.9^[c](#TFN7){ref-type="table-fn"}^   39.9 ± 0.9^[d](#TFN8){ref-type="table-fn"}^   40.2 ± 0.9   42.0 ± 1.0   43.7 ± 1.4                                    40.8 ± 0.8

Means ± SEM differ (*P* \< 0.05)

Means ± SEM differ (*P* \< 0.05)

Means ± SEM differ (*P* \< 0.10). Newborn F2 lambs born to offspring from obese ewes fed 150% NRC recommendations (OBF2) and control ewes fed 100% NRC recommendations (CONF2). CRL= Crown Rump Length; BPD= Biparietal Distance; RH=Right Humerus Length; LH= Left Humerus Length; TG=Thoracic Girth; AG=Abdominal Girth.

Means ± SEM differ (*P* \< 0.10). Newborn F2 lambs born to offspring from obese ewes fed 150% NRC recommendations (OBF2) and control ewes fed 100% NRC recommendations (CONF2). CRL= Crown Rump Length; BPD= Biparietal Distance; RH=Right Humerus Length; LH= Left Humerus Length; TG=Thoracic Girth; AG=Abdominal Girth.
